- Home
- CRMD vs CHI Comparison
CRMD vs CHI Comparison
Compare CRMD & CHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- CHI
- Stock Information
- Founded
- CRMD 2006
- CHI 2002
- Country
- CRMD United States
- CHI United States
- Employees
- CRMD N/A
- CHI N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- CHI Investment Managers
- Sector
- CRMD Health Care
- CHI Finance
- Exchange
- CRMD Nasdaq
- CHI Nasdaq
- Market Cap
- CRMD 901.8M
- CHI 820.8M
- IPO Year
- CRMD 2010
- CHI N/A
- Fundamental
- Price
- CRMD $13.69
- CHI $10.33
- Analyst Decision
- CRMD Strong Buy
- CHI
- Analyst Count
- CRMD 7
- CHI 0
- Target Price
- CRMD $16.83
- CHI N/A
- AVG Volume (30 Days)
- CRMD 3.4M
- CHI 186.2K
- Earning Date
- CRMD 08-07-2025
- CHI 01-01-0001
- Dividend Yield
- CRMD N/A
- CHI 9.90%
- EPS Growth
- CRMD N/A
- CHI N/A
- EPS
- CRMD 0.79
- CHI N/A
- Revenue
- CRMD $121,484,498.00
- CHI N/A
- Revenue This Year
- CRMD $404.81
- CHI N/A
- Revenue Next Year
- CRMD $56.11
- CHI N/A
- P/E Ratio
- CRMD $17.30
- CHI N/A
- Revenue Growth
- CRMD 14970.29
- CHI N/A
- 52 Week Low
- CRMD $4.87
- CHI $9.70
- 52 Week High
- CRMD $17.43
- CHI $11.61
- Technical
- Relative Strength Index (RSI)
- CRMD 65.34
- CHI 50.98
- Support Level
- CRMD $12.80
- CHI $10.10
- Resistance Level
- CRMD $13.56
- CHI $10.41
- Average True Range (ATR)
- CRMD 0.86
- CHI 0.11
- MACD
- CRMD 0.27
- CHI -0.01
- Stochastic Oscillator
- CRMD 84.47
- CHI 71.87
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About CHI Calamos Convertible Opportunities and Income Fund
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.